Lancet MicrobePub Date : 2025-03-15DOI: 10.1016/j.lanmic.2025.101117
Tom A Yates, Daniel J Grint
{"title":"Primary efficacy endpoints in phase 3 non-inferiority trials to establish new tuberculosis treatment regimens should only include microbiological outcomes.","authors":"Tom A Yates, Daniel J Grint","doi":"10.1016/j.lanmic.2025.101117","DOIUrl":"https://doi.org/10.1016/j.lanmic.2025.101117","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101117"},"PeriodicalIF":20.9,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143659129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lancet MicrobePub Date : 2025-03-13DOI: 10.1016/j.lanmic.2025.101116
Kai Zhou, Zhiqiang Song
{"title":"Eradication efficacy and the effect of vonoprazan-amoxicillin dual therapy on gut microbiota and antibiotic resistome.","authors":"Kai Zhou, Zhiqiang Song","doi":"10.1016/j.lanmic.2025.101116","DOIUrl":"https://doi.org/10.1016/j.lanmic.2025.101116","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101116"},"PeriodicalIF":20.9,"publicationDate":"2025-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143639650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lancet MicrobePub Date : 2025-03-12DOI: 10.1016/j.lanmic.2024.101018
Mitchell J Mumby, Jessica L Prodger, Jada Hackman, Sharada Saraf, Xianming Zhu, Roux-Cil Ferreira, Stephen Tomusange, Samiri Jamiru, Aggrey Anok, Taddeo Kityamuweesi, Paul Buule, Corby Fink, Cassandra R Edgar, Steven M Trothen, Gregory A Dekaban, Erin E Brown, Adam A Capoferri, Owen R Baker, Ethan Klock, Jernelle C Miller, Charles Kirby, Briana Lynch, Aaron A R Tobian, Art F Y Poon, Thomas C Quinn, Ronald M Galiwango, Steven J Reynolds, Andrew D Redd, Jimmy D Dikeakos
{"title":"Association between HIV-1 Nef-mediated MHC-I downregulation and the maintenance of the replication-competent latent viral reservoir in individuals with virally suppressed HIV-1 in Uganda: an exploratory cohort study.","authors":"Mitchell J Mumby, Jessica L Prodger, Jada Hackman, Sharada Saraf, Xianming Zhu, Roux-Cil Ferreira, Stephen Tomusange, Samiri Jamiru, Aggrey Anok, Taddeo Kityamuweesi, Paul Buule, Corby Fink, Cassandra R Edgar, Steven M Trothen, Gregory A Dekaban, Erin E Brown, Adam A Capoferri, Owen R Baker, Ethan Klock, Jernelle C Miller, Charles Kirby, Briana Lynch, Aaron A R Tobian, Art F Y Poon, Thomas C Quinn, Ronald M Galiwango, Steven J Reynolds, Andrew D Redd, Jimmy D Dikeakos","doi":"10.1016/j.lanmic.2024.101018","DOIUrl":"https://doi.org/10.1016/j.lanmic.2024.101018","url":null,"abstract":"<p><strong>Background: </strong>The persistence of a replication-competent latent viral reservoir (RC-LVR) during antiretroviral therapy (ART) is a barrier to the development of a cure for HIV-1, but the role of viral genes in influencing RC-LVR size is unclear. We aimed to assess whether the magnitude by which the HIV-1 accessory protein Nef evades the adaptive immune response by downregulating MHC-I or CD4, or both, from the surface of infected cells is associated with the rate at which the RC-LVR in people with HIV-1 changes during long-term ART (>1 year).</p><p><strong>Methods: </strong>We conducted an exploratory cohort study in which nef genes were sequenced from outgrowth viruses derived from the quantitative viral outgrowth assay (QVOA) for a group of people with ART-suppressed HIV-1 in Uganda between 2015 and 2020. Study participants were selected from the Rakai Health Sciences Program (RHSP) LVR cohort, a cohort of 90 adults (aged ≥18 years) who were HIV-1 positive, receiving ART, and had maintained viral suppression for at least 1 year at the time of study enrolment. For this study, participants were required to have available p24<sup>+</sup> QVOA wells that contained a single viral outgrowth isolate, as assessed by next-generation sequencing. In cases where further sequencing identified wells containing multiple viral clones, all sequenced nef variants were included for functional analysis. The unique isolated nef variants were used to generate pseudoviruses, which were employed to measure cell surface CD4 and MHC-I downregulation in infected CD4<sup>+</sup> Sup-T1 cells via flow cytometry. The size and rate of change of the RC-LVR in participants was estimated using previous QVOA results and a Bayesian model. We then assessed whether a correlation existed between the extent to which the Nef proteins downregulated cell surface MHC-I and CD4 and the calculated RC-LVR rate of change during the study period.</p><p><strong>Findings: </strong>14 (15%) of 90 participants from the RHSP cohort met the inclusion criteria and were enrolled in this study. 49 nef sequences were isolated from these participants. We observed variability in participant-derived Nef-mediated cell surface MHC-I downregulation (median 114·88% [IQR 104·93-121·51] of the downregulation capacity of NL4-3 Nef) and CD4 downregulation (94·50% [84·05-100·16] of NL4-3 Nef). The estimated rate of change of the RC-LVR was positive for four participants. For one donor, the rate of change was significantly positive (7·4 × 10<sup>-4</sup> logit infectious units per million [IUPM] per day [95% credibility interval 3·2 × 10<sup>-4</sup> to 1·2 × 10<sup>-3</sup>]) over the course of the study period (2015-20). The estimated rate of change of the RC-LVR for the remaining ten participants was negative, and significantly negative in four donors (-1·1 × 10<sup>-3</sup> logit IUPM per day [95% credibility interval -1·8 × 10<sup>-3</sup> to -3·7 × 10<sup>-4</sup>]; -1·4 × 10<sup>-3</sup> [-2","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101018"},"PeriodicalIF":20.9,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143634870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lancet MicrobePub Date : 2025-03-11DOI: 10.1016/j.lanmic.2025.101115
Ishir Sharma, Richard C Wilson, Nina Zhu, Timothy Miles Rawson
{"title":"Does anticancer therapy directly contribute to antimicrobial resistance?","authors":"Ishir Sharma, Richard C Wilson, Nina Zhu, Timothy Miles Rawson","doi":"10.1016/j.lanmic.2025.101115","DOIUrl":"https://doi.org/10.1016/j.lanmic.2025.101115","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101115"},"PeriodicalIF":20.9,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143630894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lancet MicrobePub Date : 2025-03-10DOI: 10.1016/j.lanmic.2025.101113
Ziad A Memish, Majid M Alshamrani, Ali M Albarrak, Shahul Ebrahim
{"title":"Vaccine shortage affects airline and public health efforts to prevent meningitis during Umrah.","authors":"Ziad A Memish, Majid M Alshamrani, Ali M Albarrak, Shahul Ebrahim","doi":"10.1016/j.lanmic.2025.101113","DOIUrl":"https://doi.org/10.1016/j.lanmic.2025.101113","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101113"},"PeriodicalIF":20.9,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143626444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lancet MicrobePub Date : 2025-03-10DOI: 10.1016/j.lanmic.2024.101033
Mosoka P Fallah, Collin Van Ryn, J Soka Moses, Moses Badio, Tamba Fayiah, Kumblytee Johnson, Dehkontee Gayedyu-Dennis, Allen O Eghrari, Sheri D Weiser, Travis C Porco, Jeffrey N Martin, Michael J Peluso, David R McIlwain, Bonnie Dighero-Kemp, Elizabeth Higgs, Lisa E Hensley, George W Rutherford, Cavan Reilly, J Daniel Kelly
{"title":"Associations of inflammatory markers with post-acute clinical findings among survivors of Ebola virus disease with and without viral RNA shedding in the semen in Liberia: a nested case-control study.","authors":"Mosoka P Fallah, Collin Van Ryn, J Soka Moses, Moses Badio, Tamba Fayiah, Kumblytee Johnson, Dehkontee Gayedyu-Dennis, Allen O Eghrari, Sheri D Weiser, Travis C Porco, Jeffrey N Martin, Michael J Peluso, David R McIlwain, Bonnie Dighero-Kemp, Elizabeth Higgs, Lisa E Hensley, George W Rutherford, Cavan Reilly, J Daniel Kelly","doi":"10.1016/j.lanmic.2024.101033","DOIUrl":"https://doi.org/10.1016/j.lanmic.2024.101033","url":null,"abstract":"<p><strong>Background: </strong>A high proportion of survivors of Ebola virus disease (EVD) have post-acute sequelae of EVD (PASE), but the relationship between inflammation and PASE pathogenesis is poorly understood. This study tests the hypothesis that inflammation is associated with PASE among survivors with and without viral RNA shedding in the semen.</p><p><strong>Methods: </strong>This was a case-control study nested in a longitudinal cohort that recruited confirmed survivors of EVD and their uninfected contacts from the 2013-16 EVD epidemic in Liberia, starting on June 1, 2015. We included participants aged at least 18 years with clinical data and plasma available at cohort baseline for analysis. A semen donation substudy tested male survivors for Ebola virus RNA shedding in the semen. A sex-stratified and survivor-stratified random sample of cases (survivors) and controls (contacts) was obtained to select stored baseline plasma samples for cytokine testing of markers of inflammation, immune regulation, and antiviral responses. Serostatus of cases and controls was confirmed by Filovirus Animal Nonclinical Group assay. We identified inflammatory markers (adjusted p≤0·05) elevated in cases compared with controls and then used these biomarkers in analyses comparing survivors with and without pre-specified PASE-associated clinical findings (self-reported symptoms and abnormal examination findings). Survivors with viral RNA shedding in the semen formed subgroup analyses.</p><p><strong>Findings: </strong>Our analysis cohort consisted of 1044 participants (594 survivors of EVD and 450 uninfected contacts); 515 (49·3%) were female and 529 (50·7%) were male. The subcohort of 243 male survivors with data on viral shedding included 81 (33%) participants with viral shedding in semen. Median time from acute EVD to baseline was 317 days (IQR 271-366). Survivors of EVD showed a pattern of elevated inflammatory markers indicative of macrophage (MCP-1, IL-1β, and M-CSF) and angiogenic factor activation (VEGF-A) compared with controls (adjusted p<0·05). In survivors with viral shedding in the semen compared with controls, VEGF-A was the only inflammatory marker that was significantly higher (adjusted p<0·001). After restricting the analysis to survivors, each inflammatory marker had a specific pattern of clinical findings. Higher levels of IL-1β were associated with higher odds of urinary frequency (p=0·002), musculoskeletal abnormalities (p=0·003), and abdominal abnormalities (p=0·03). By contrast, higher levels of MCP-1 were associated with lower odds of the same clinical findings. M-CSF was the only inflammatory marker associated with lower odds of joint pain (p=0·04). Higher levels of VEGF-A were associated with higher odds of abnormal chest findings in the overall survivor group (p=0·02) and in the subgroup with viral shedding in the semen (p=0·02).</p><p><strong>Interpretation: </strong>We found evidence of distinct biological pathways for PASE. Altho","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101033"},"PeriodicalIF":20.9,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143626442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lancet MicrobePub Date : 2025-03-06DOI: 10.1016/j.lanmic.2025.101093
Edward P Rybicki, Anna-Lise Williamson, Marietjie Venter
{"title":"Virology Africa 2024: a short report.","authors":"Edward P Rybicki, Anna-Lise Williamson, Marietjie Venter","doi":"10.1016/j.lanmic.2025.101093","DOIUrl":"https://doi.org/10.1016/j.lanmic.2025.101093","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101093"},"PeriodicalIF":20.9,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lancet MicrobePub Date : 2025-03-06DOI: 10.1016/j.lanmic.2025.101112
Amir Ghaemi, Nader Ebrahimi
{"title":"Analysis of H5N1 2.3.4.4b sublineage origins and K193 and N193 prevalence in human isolates.","authors":"Amir Ghaemi, Nader Ebrahimi","doi":"10.1016/j.lanmic.2025.101112","DOIUrl":"https://doi.org/10.1016/j.lanmic.2025.101112","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101112"},"PeriodicalIF":20.9,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143587830","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}